vemurafenib [cytosol]

Stable Identifier
R-ALL-6802253
Type
ChemicalDrug
Compartment
cytosol
Locations in the PathwayBrowser
Expand all
Literature References
PubMed ID Title Journal Year
22028422 Vemurafenib (PLX4032): an orally available inhibitor of mutated BRAF for the treatment of metastatic melanoma

Heakal, Y, Kester, M, Savage, S

Ann Pharmacother 2011
22083257 Vemurafenib and BRAF inhibition: a new class of treatment for metastatic melanoma

Luke, JJ, Hodi, FS

Clin. Cancer Res. 2012
External Reference Information
External Reference
vemurafenib [Guide to Pharmacology:5893]
Participates
as a member of
Disease
Name Identifier Synonyms
melanoma DOID:1909 Naevocarcinoma, melanoma, melanoma, malignant melanoma, morphology (morphologic abnormality), malignant melanoma NOS (morphologic abnormality), malignant melanoma (disorder), malignant melanoma, malignant melanoma, malignant melanoma, malignant melanoma
cancer DOID:162 malignant tumor, malignant neoplasm, primary cancer
Cross References
Mondo
ChEBI
Pharos - Ligands
PharmacoDB
Cite Us!